Orally Disintegrating Tablet Excipient Market Report

Global and Region Orally Disintegrating Tablet Excipient Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：216
  • REPORT CODE：GMM1005936
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Orally Disintegrating Tablet Excipient market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Orally Disintegrating Tablet Excipientmarket, defines the market attractiveness level of Orally Disintegrating Tablet Excipient market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Orally Disintegrating Tablet Excipient industry, describes the types of Orally Disintegrating Tablet Excipient market, the applications of major players and the market size, and deeply analyzes the current situation of the global Orally Disintegrating Tablet Excipient market and the development prospects and opportunities of Orally Disintegrating Tablet Excipient industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Orally Disintegrating Tablet Excipient market in Chapter 13.

    By Player:

    • Shin-Etsu

    • BASF

    • JRS Pharma

    • Roquette

    • Anhui Sunhere Pharmaceutical

    • McePharma (Vivesa holding)

    • Merck KGaA

    • Meggle Pharma

    • Cargill Incorporated

    • DFE Pharma

    • Ashland

    • ABF Ingredients

    • Fuji Chemical Industries

    • Daicel Corporation

    • Evonik

    By Type:

    • Binders

    • Glidents

    • Diluents

    • Disintegrants

    • Others

    By End-User:

    • Anti-Psychotics Drug

    • Anti-Epileptics Drug

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Orally Disintegrating Tablet Excipient Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Orally Disintegrating Tablet Excipient Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Orally Disintegrating Tablet Excipient Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Orally Disintegrating Tablet Excipient Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Orally Disintegrating Tablet Excipient Market Analysis and Outlook to 2022

    • 7.1 Global Orally Disintegrating Tablet Excipient Consumption (2017-2022)

    • 7.2 United States Orally Disintegrating Tablet Excipient Consumption (2017-2022)

    • 7.3 Europe Orally Disintegrating Tablet Excipient Consumption (2017-2022)

    • 7.4 China Orally Disintegrating Tablet Excipient Consumption (2017-2022)

    • 7.5 Japan Orally Disintegrating Tablet Excipient Consumption (2017-2022)

    • 7.6 India Orally Disintegrating Tablet Excipient Consumption (2017-2022)

    • 7.7 South Korea Orally Disintegrating Tablet Excipient Consumption (2017-2022)

    8 Region and Country-wise Orally Disintegrating Tablet Excipient Market Analysis and Outlook to 2028

    • 8.1 Global Orally Disintegrating Tablet Excipient Consumption Forecast (2022-2028)

    • 8.2 United States Orally Disintegrating Tablet Excipient Consumption Forecast (2022-2028)

    • 8.3 Europe Orally Disintegrating Tablet Excipient Consumption Forecast (2022-2028)

    • 8.4 China Orally Disintegrating Tablet Excipient Consumption Forecast (2022-2028)

    • 8.5 Japan Orally Disintegrating Tablet Excipient Consumption Forecast (2022-2028)

    • 8.6 India Orally Disintegrating Tablet Excipient Consumption Forecast (2022-2028)

    • 8.7 South Korea Orally Disintegrating Tablet Excipient Consumption Forecast (2022-2028)

    9 Global Orally Disintegrating Tablet Excipient Market Outlook by Types and Applications to 2022

    • 9.1 Global Orally Disintegrating Tablet Excipient Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Binders Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Glidents Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Diluents Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Disintegrants Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Orally Disintegrating Tablet Excipient Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Anti-Psychotics Drug Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Anti-Epileptics Drug Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Orally Disintegrating Tablet Excipient Market Outlook by Types and Applications to 2028

    • 10.1 Global Orally Disintegrating Tablet Excipient Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Binders Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Glidents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Diluents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Disintegrants Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Orally Disintegrating Tablet Excipient Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Anti-Psychotics Drug Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Anti-Epileptics Drug Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Orally Disintegrating Tablet Excipient Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Orally Disintegrating Tablet Excipient Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Orally Disintegrating Tablet Excipient Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Orally Disintegrating Tablet Excipient Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Orally Disintegrating Tablet Excipient Market Competitive Analysis

    • 14.1 Shin-Etsu

      • 14.1.1 Shin-Etsu Company Details

      • 14.1.2 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Shin-Etsu Orally Disintegrating Tablet Excipient Product and Service

    • 14.2 BASF

      • 14.2.1 BASF Company Details

      • 14.2.2 BASF Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 BASF Orally Disintegrating Tablet Excipient Product and Service

    • 14.3 JRS Pharma

      • 14.3.1 JRS Pharma Company Details

      • 14.3.2 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 JRS Pharma Orally Disintegrating Tablet Excipient Product and Service

    • 14.4 Roquette

      • 14.4.1 Roquette Company Details

      • 14.4.2 Roquette Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Roquette Orally Disintegrating Tablet Excipient Product and Service

    • 14.5 Anhui Sunhere Pharmaceutical

      • 14.5.1 Anhui Sunhere Pharmaceutical Company Details

      • 14.5.2 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product and Service

    • 14.6 McePharma (Vivesa holding)

      • 14.6.1 McePharma (Vivesa holding) Company Details

      • 14.6.2 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product and Service

    • 14.7 Merck KGaA

      • 14.7.1 Merck KGaA Company Details

      • 14.7.2 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Product and Service

    • 14.8 Meggle Pharma

      • 14.8.1 Meggle Pharma Company Details

      • 14.8.2 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Meggle Pharma Orally Disintegrating Tablet Excipient Product and Service

    • 14.9 Cargill Incorporated

      • 14.9.1 Cargill Incorporated Company Details

      • 14.9.2 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Product and Service

    • 14.10 DFE Pharma

      • 14.10.1 DFE Pharma Company Details

      • 14.10.2 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 DFE Pharma Orally Disintegrating Tablet Excipient Product and Service

    • 14.11 Ashland

      • 14.11.1 Ashland Company Details

      • 14.11.2 Ashland Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Ashland Orally Disintegrating Tablet Excipient Product and Service

    • 14.12 ABF Ingredients

      • 14.12.1 ABF Ingredients Company Details

      • 14.12.2 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 ABF Ingredients Orally Disintegrating Tablet Excipient Product and Service

    • 14.13 Fuji Chemical Industries

      • 14.13.1 Fuji Chemical Industries Company Details

      • 14.13.2 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product and Service

    • 14.14 Daicel Corporation

      • 14.14.1 Daicel Corporation Company Details

      • 14.14.2 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Product and Service

    • 14.15 Evonik

      • 14.15.1 Evonik Company Details

      • 14.15.2 Evonik Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Evonik Orally Disintegrating Tablet Excipient Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Orally Disintegrating Tablet Excipient

    • Figure Orally Disintegrating Tablet Excipient Picture

    • Table Global Orally Disintegrating Tablet Excipient Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Orally Disintegrating Tablet Excipient Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Orally Disintegrating Tablet Excipient Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Orally Disintegrating Tablet Excipient Consumption by Country (2017-2022)

    • Figure United States Orally Disintegrating Tablet Excipient Consumption and Growth Rate (2017-2022)

    • Table Europe Orally Disintegrating Tablet Excipient Consumption and Growth Rate (2017-2022)

    • Figure China Orally Disintegrating Tablet Excipient Consumption and Growth Rate (2017-2022)

    • Figure Japan Orally Disintegrating Tablet Excipient Consumption and Growth Rate (2017-2022)

    • Figure India Orally Disintegrating Tablet Excipient Consumption and Growth Rate (2017-2022)

    • Figure South Korea Orally Disintegrating Tablet Excipient Consumption and Growth Rate (2017-2022)

    • Figure Global Orally Disintegrating Tablet Excipient Consumption Forecast by Country (2022-2028)

    • Figure United States Orally Disintegrating Tablet Excipient Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Orally Disintegrating Tablet Excipient Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Orally Disintegrating Tablet Excipient Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Orally Disintegrating Tablet Excipient Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Orally Disintegrating Tablet Excipient Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Orally Disintegrating Tablet Excipient Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Binders Consumption and Growth Rate (2017-2022)

    • Figure Global Glidents Consumption and Growth Rate (2017-2022)

    • Figure Global Diluents Consumption and Growth Rate (2017-2022)

    • Figure Global Disintegrants Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-Psychotics Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-Epileptics Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Binders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glidents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diluents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Disintegrants Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-Psychotics Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-Epileptics Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Orally Disintegrating Tablet Excipient Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Orally Disintegrating Tablet Excipient Export by Region (Top 5 Countries) (2017-2028)

    • Table Shin-Etsu (Foundation Year, Company Profile and etc.)

    • Table Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shin-Etsu Orally Disintegrating Tablet Excipient Product and Service

    • Table BASF (Foundation Year, Company Profile and etc.)

    • Table BASF Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table BASF Orally Disintegrating Tablet Excipient Product and Service

    • Table JRS Pharma (Foundation Year, Company Profile and etc.)

    • Table JRS Pharma Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table JRS Pharma Orally Disintegrating Tablet Excipient Product and Service

    • Table Roquette (Foundation Year, Company Profile and etc.)

    • Table Roquette Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roquette Orally Disintegrating Tablet Excipient Product and Service

    • Table Anhui Sunhere Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product and Service

    • Table McePharma (Vivesa holding) (Foundation Year, Company Profile and etc.)

    • Table McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product and Service

    • Table Merck KGaA (Foundation Year, Company Profile and etc.)

    • Table Merck KGaA Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck KGaA Orally Disintegrating Tablet Excipient Product and Service

    • Table Meggle Pharma (Foundation Year, Company Profile and etc.)

    • Table Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Meggle Pharma Orally Disintegrating Tablet Excipient Product and Service

    • Table Cargill Incorporated (Foundation Year, Company Profile and etc.)

    • Table Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cargill Incorporated Orally Disintegrating Tablet Excipient Product and Service

    • Table DFE Pharma (Foundation Year, Company Profile and etc.)

    • Table DFE Pharma Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table DFE Pharma Orally Disintegrating Tablet Excipient Product and Service

    • Table Ashland (Foundation Year, Company Profile and etc.)

    • Table Ashland Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ashland Orally Disintegrating Tablet Excipient Product and Service

    • Table ABF Ingredients (Foundation Year, Company Profile and etc.)

    • Table ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table ABF Ingredients Orally Disintegrating Tablet Excipient Product and Service

    • Table Fuji Chemical Industries (Foundation Year, Company Profile and etc.)

    • Table Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product and Service

    • Table Daicel Corporation (Foundation Year, Company Profile and etc.)

    • Table Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daicel Corporation Orally Disintegrating Tablet Excipient Product and Service

    • Table Evonik (Foundation Year, Company Profile and etc.)

    • Table Evonik Orally Disintegrating Tablet Excipient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Evonik Orally Disintegrating Tablet Excipient Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US